Dominic Piscitelli Insider Trades & Stock Holdings

Chief Financial Officer · ORIC Pharmaceuticals, Inc. · Latest filing Oct 20, 2026

Dominic Piscitelli, Chief Financial Officer at ORIC Pharmaceuticals, Inc. has 3 Form 4 trades on file since Sep 24, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($378.75K), net -$378.75K. Latest filing: disposed of 14K shares of $ORIC on Oct 20, 2026 at $13.53.

Trades on file
3
Open-market bought
$0
Open-market sold
$378.75K
Net open-market
-$378.75K
Shares held ($ORIC)
69.83K
Latest filing
Oct 20, 2026

Shares held by Dominic Piscitelli

Shares owned after the most recent Form 4 for each company.

All insider trades by Dominic Piscitelli

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$ORIC Sell (Open-market sale) 10b5-1 14K $13.53 $189.39K 69.83K -16.70% Chief Financial Officer SEC Read
$ORIC Sell (Open-market sale) 10b5-1 13.40K $13.53 $181.26K 69.83K -16.10% -5.9% Chief Financial Officer SEC —
$ORIC Sell (Open-market sale) 10b5-1 600 $13.50 $8.10K 69.83K -0.85% -5.0% Chief Financial Officer SEC —

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Dominic Piscitelli traded

Frequently asked questions

Has Dominic Piscitelli been buying or selling stock?

Dominic Piscitelli has 0 open-market purchases and 3 open-market sales on file, net -$378.75K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Dominic Piscitelli's latest insider trade?

disposed of 14K shares of $ORIC on Oct 20, 2026 at $13.53.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions